1 Market Overview of Dilated Cardiomyopathy Therapeutic 1.1 Dilated Cardiomyopathy Therapeutic Market Overview 1.1.1 Dilated Cardiomyopathy Therapeutic Product Scope 1.1.2 Market Status and Outlook 1.2 Global Dilated Cardiomyopathy Therapeutic Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Dilated Cardiomyopathy Therapeutic Market Size by Region (2015-2026) 1.4 Global Dilated Cardiomyopathy Therapeutic Historic Market Size by Region (2015-2020) 1.5 Global Dilated Cardiomyopathy Therapeutic Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) 1.6.1 North America Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) 1.6.2 Europe Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) 1.6.4 Latin America Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) 2 Dilated Cardiomyopathy Therapeutic Market Overview by Type 2.1 Global Dilated Cardiomyopathy Therapeutic Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Dilated Cardiomyopathy Therapeutic Historic Market Size by Type (2015-2020) 2.3 Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Type (2021-2026) 2.4 Aldosterone antagonists 2.5 Angiotensin-converting enzyme (ACE) inhibitors 2.6 Angiotensin II receptor blockers (ARBs) 2.7 Beta-blockers 3 Dilated Cardiomyopathy Therapeutic Market Overview by Application 3.1 Global Dilated Cardiomyopathy Therapeutic Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Dilated Cardiomyopathy Therapeutic Historic Market Size by Application (2015-2020) 3.3 Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Application (2021-2026) 3.4 Hospitals 3.5 Academic Institutions 4 Global Dilated Cardiomyopathy Therapeutic Competition Analysis by Players 4.1 Global Dilated Cardiomyopathy Therapeutic Market Size by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dilated Cardiomyopathy Therapeutic as of 2019) 4.3 Date of Key Manufacturers Enter into Dilated Cardiomyopathy Therapeutic Market 4.4 Global Top Players Dilated Cardiomyopathy Therapeutic Headquarters and Area Served 4.5 Key Players Dilated Cardiomyopathy Therapeutic Product Solution and Service 4.6 Competitive Status 4.6.1 Dilated Cardiomyopathy Therapeutic Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Array BioPharma, Inc. 5.1.1 Array BioPharma, Inc. Profile 5.1.2 Array BioPharma, Inc. Main Business 5.1.3 Array BioPharma, Inc. Dilated Cardiomyopathy Therapeutic Products, Services and Solutions 5.1.4 Array BioPharma, Inc. Dilated Cardiomyopathy Therapeutic Revenue (US$ Million) & (2015-2020) 5.1.5 Array BioPharma, Inc. Recent Developments 5.2 AstraZeneca plc. 5.2.1 AstraZeneca plc. Profile 5.2.2 AstraZeneca plc. Main Business 5.2.3 AstraZeneca plc. Dilated Cardiomyopathy Therapeutic Products, Services and Solutions 5.2.4 AstraZeneca plc. Dilated Cardiomyopathy Therapeutic Revenue (US$ Million) & (2015-2020) 5.2.5 AstraZeneca plc. Recent Developments 5.3 Celladon Corporation 5.5.1 Celladon Corporation Profile 5.3.2 Celladon Corporation Main Business 5.3.3 Celladon Corporation Dilated Cardiomyopathy Therapeutic Products, Services and Solutions 5.3.4 Celladon Corporation Dilated Cardiomyopathy Therapeutic Revenue (US$ Million) & (2015-2020) 5.3.5 GlaxoSmithKline plc Recent Developments 5.4 GlaxoSmithKline plc 5.4.1 GlaxoSmithKline plc Profile 5.4.2 GlaxoSmithKline plc Main Business 5.4.3 GlaxoSmithKline plc Dilated Cardiomyopathy Therapeutic Products, Services and Solutions 5.4.4 GlaxoSmithKline plc Dilated Cardiomyopathy Therapeutic Revenue (US$ Million) & (2015-2020) 5.4.5 GlaxoSmithKline plc Recent Developments 5.5 Janssen Pharmaceuticals, Inc. (J&J) 5.5.1 Janssen Pharmaceuticals, Inc. (J&J) Profile 5.5.2 Janssen Pharmaceuticals, Inc. (J&J) Main Business 5.5.3 Janssen Pharmaceuticals, Inc. (J&J) Dilated Cardiomyopathy Therapeutic Products, Services and Solutions 5.5.4 Janssen Pharmaceuticals, Inc. (J&J) Dilated Cardiomyopathy Therapeutic Revenue (US$ Million) & (2015-2020) 5.5.5 Janssen Pharmaceuticals, Inc. (J&J) Recent Developments 5.6 Merck & Co., Inc. 5.6.1 Merck & Co., Inc. Profile 5.6.2 Merck & Co., Inc. Main Business 5.6.3 Merck & Co., Inc. Dilated Cardiomyopathy Therapeutic Products, Services and Solutions 5.6.4 Merck & Co., Inc. Dilated Cardiomyopathy Therapeutic Revenue (US$ Million) & (2015-2020) 5.6.5 Merck & Co., Inc. Recent Developments 5.7 Novartis International AG 5.7.1 Novartis International AG Profile 5.7.2 Novartis International AG Main Business 5.7.3 Novartis International AG Dilated Cardiomyopathy Therapeutic Products, Services and Solutions 5.7.4 Novartis International AG Dilated Cardiomyopathy Therapeutic Revenue (US$ Million) & (2015-2020) 5.7.5 Novartis International AG Recent Developments 5.8 Pfizer, Inc. 5.8.1 Pfizer, Inc. Profile 5.8.2 Pfizer, Inc. Main Business 5.8.3 Pfizer, Inc. Dilated Cardiomyopathy Therapeutic Products, Services and Solutions 5.8.4 Pfizer, Inc. Dilated Cardiomyopathy Therapeutic Revenue (US$ Million) & (2015-2020) 5.8.5 Pfizer, Inc. Recent Developments 5.9 Sanofi S.A. 5.9.1 Sanofi S.A. Profile 5.9.2 Sanofi S.A. Main Business 5.9.3 Sanofi S.A. Dilated Cardiomyopathy Therapeutic Products, Services and Solutions 5.9.4 Sanofi S.A. Dilated Cardiomyopathy Therapeutic Revenue (US$ Million) & (2015-2020) 5.9.5 Sanofi S.A. Recent Developments 5.10 Teva Pharmaceutical Industries Ltd. 5.10.1 Teva Pharmaceutical Industries Ltd. Profile 5.10.2 Teva Pharmaceutical Industries Ltd. Main Business 5.10.3 Teva Pharmaceutical Industries Ltd. Dilated Cardiomyopathy Therapeutic Products, Services and Solutions 5.10.4 Teva Pharmaceutical Industries Ltd. Dilated Cardiomyopathy Therapeutic Revenue (US$ Million) & (2015-2020) 5.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments 5.11 Vericel Corporation 5.11.1 Vericel Corporation Profile 5.11.2 Vericel Corporation Main Business 5.11.3 Vericel Corporation Dilated Cardiomyopathy Therapeutic Products, Services and Solutions 5.11.4 Vericel Corporation Dilated Cardiomyopathy Therapeutic Revenue (US$ Million) & (2015-2020) 5.11.5 Vericel Corporation Recent Developments 6 North America 6.1 North America Dilated Cardiomyopathy Therapeutic Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Dilated Cardiomyopathy Therapeutic Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Dilated Cardiomyopathy Therapeutic Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Dilated Cardiomyopathy Therapeutic Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Dilated Cardiomyopathy Therapeutic Market Size by Region (2015-2020) (US$ Million) Table 3. Global Dilated Cardiomyopathy Therapeutic Market Size Share by Region (2015-2020) Table 4. Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size Share by Region (2021-2026) Table 6. Global Dilated Cardiomyopathy Therapeutic Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Dilated Cardiomyopathy Therapeutic Market Size by Type (2015-2020) (US$ Million) Table 8. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Type (2015-2020) Table 9. Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Type (2021-2026) Table 11. Global Dilated Cardiomyopathy Therapeutic Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Dilated Cardiomyopathy Therapeutic Market Size by Application (2015-2020) (US$ Million) Table 13. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Application (2015-2020) Table 14. Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Application (2021-2026) Table 16. Global Dilated Cardiomyopathy Therapeutic Revenue (US$ Million) by Players (2015-2020) Table 17. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dilated Cardiomyopathy Therapeutic as of 2019) Table 19. Date of Key Manufacturers Enter into Dilated Cardiomyopathy Therapeutic Market Table 20. Global Dilated Cardiomyopathy Therapeutic Top Players Headquarters and Area Served Table 21. Dilated Cardiomyopathy Therapeutic Product Solution and Service Table 22. Global Dilated Cardiomyopathy Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Array BioPharma, Inc. Basic Information List Table 25. Array BioPharma, Inc. Description and Business Overview Table 26. Array BioPharma, Inc. Dilated Cardiomyopathy Therapeutic Products, Services and Solutions Table 27. Revenue (Million US$) in Dilated Cardiomyopathy Therapeutic Business of Array BioPharma, Inc. (2015-2020) Table 28. Array BioPharma, Inc. Recent Developments Table 29. AstraZeneca plc. Basic Information List Table 30. AstraZeneca plc. Description and Business Overview Table 31. AstraZeneca plc. Dilated Cardiomyopathy Therapeutic Products, Services and Solutions Table 32. Revenue (Million US$) in Dilated Cardiomyopathy Therapeutic Business of AstraZeneca plc. (2015-2020) Table 33. AstraZeneca plc. Recent Developments Table 34. Celladon Corporation Basic Information List Table 35. Celladon Corporation Description and Business Overview Table 36. Celladon Corporation Dilated Cardiomyopathy Therapeutic Products, Services and Solutions Table 37. Revenue (Million US$) in Dilated Cardiomyopathy Therapeutic Business of Celladon Corporation (2015-2020) Table 38. Celladon Corporation Recent Developments Table 39. GlaxoSmithKline plc Basic Information List Table 40. GlaxoSmithKline plc Description and Business Overview Table 41. GlaxoSmithKline plc Dilated Cardiomyopathy Therapeutic Products, Services and Solutions Table 42. Revenue (Million US$) in Dilated Cardiomyopathy Therapeutic Business of GlaxoSmithKline plc (2015-2020) Table 43. GlaxoSmithKline plc Recent Developments Table 44. Janssen Pharmaceuticals, Inc. (J&J) Basic Information List Table 45. Janssen Pharmaceuticals, Inc. (J&J) Description and Business Overview Table 46. Janssen Pharmaceuticals, Inc. (J&J) Dilated Cardiomyopathy Therapeutic Products, Services and Solutions Table 47. Revenue (Million US$) in Dilated Cardiomyopathy Therapeutic Business of Janssen Pharmaceuticals, Inc. (J&J) (2015-2020) Table 48. Janssen Pharmaceuticals, Inc. (J&J) Recent Developments Table 49. Merck & Co., Inc. Basic Information List Table 50. Merck & Co., Inc. Description and Business Overview Table 51. Merck & Co., Inc. Dilated Cardiomyopathy Therapeutic Products, Services and Solutions Table 52. Revenue (Million US$) in Dilated Cardiomyopathy Therapeutic Business of Merck & Co., Inc. (2015-2020) Table 53. Merck & Co., Inc. Recent Developments Table 54. Novartis International AG Basic Information List Table 55. Novartis International AG Description and Business Overview Table 56. Novartis International AG Dilated Cardiomyopathy Therapeutic Products, Services and Solutions Table 57. Revenue (Million US$) in Dilated Cardiomyopathy Therapeutic Business of Novartis International AG (2015-2020) Table 58. Novartis International AG Recent Developments Table 59. Pfizer, Inc. Basic Information List Table 60. Pfizer, Inc. Description and Business Overview Table 61. Pfizer, Inc. Dilated Cardiomyopathy Therapeutic Products, Services and Solutions Table 62. Revenue (Million US$) in Dilated Cardiomyopathy Therapeutic Business of Pfizer, Inc. (2015-2020) Table 63. Pfizer, Inc. Recent Developments Table 64. Sanofi S.A. Basic Information List Table 65. Sanofi S.A. Description and Business Overview Table 66. Sanofi S.A. Dilated Cardiomyopathy Therapeutic Products, Services and Solutions Table 67. Revenue (Million US$) in Dilated Cardiomyopathy Therapeutic Business of Sanofi S.A. (2015-2020) Table 68. Sanofi S.A. Recent Developments Table 69. Teva Pharmaceutical Industries Ltd. Basic Information List Table 70. Teva Pharmaceutical Industries Ltd. Description and Business Overview Table 71. Teva Pharmaceutical Industries Ltd. Dilated Cardiomyopathy Therapeutic Products, Services and Solutions Table 72. Revenue (Million US$) in Dilated Cardiomyopathy Therapeutic Business of Teva Pharmaceutical Industries Ltd. (2015-2020) Table 73. Teva Pharmaceutical Industries Ltd. Recent Developments Table 74. Vericel Corporation Basic Information List Table 75. Vericel Corporation Description and Business Overview Table 76. Vericel Corporation Dilated Cardiomyopathy Therapeutic Products, Services and Solutions Table 77. Revenue (Million US$) in Dilated Cardiomyopathy Therapeutic Business of Vericel Corporation (2015-2020) Table 78. Vericel Corporation Recent Developments Table 79. North America Dilated Cardiomyopathy Therapeutic Market Size by Country (2015-2020) & (US$ Million) Table 80. North America Dilated Cardiomyopathy Therapeutic Market Size Share by Country (2015-2020) Table 81. Europe Dilated Cardiomyopathy Therapeutic Market Size by Country (2015-2020) & (US$ Million) Table 82. Europe Dilated Cardiomyopathy Therapeutic Market Size Share by Country (2015-2020) Table 83. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size by Region (2015-2020) & (US$ Million) Table 84. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size Share by Region (2015-2020) (US$ Million) Table 85. Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country (2015-2020) & (US$ Million) Table 86. Latin America Dilated Cardiomyopathy Therapeutic Market Size Share by Country (2015-2020) (US$ Million) Table 87. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size by Players (2015-2020) (US$ Million) Table 88. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size Share by Players (2015-2020) (US$ Million) Table 89. Dilated Cardiomyopathy Therapeutic Market Trends Table 90. Dilated Cardiomyopathy Therapeutic Market Drivers Table 91. Dilated Cardiomyopathy Therapeutic Market Challenges Table 92. Dilated Cardiomyopathy Therapeutic Market Restriants Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Global Dilated Cardiomyopathy Therapeutic Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Dilated Cardiomyopathy Therapeutic Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Dilated Cardiomyopathy Therapeutic Market Share by Regions: 2020 VS 2026 Figure 4. North America Dilated Cardiomyopathy Therapeutic Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Dilated Cardiomyopathy Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Dilated Cardiomyopathy Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Dilated Cardiomyopathy Therapeutic Market Share by Type in 2020 & 2026 Figure 10. Aldosterone antagonists Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. Angiotensin-converting enzyme (ACE) inhibitors Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Angiotensin II receptor blockers (ARBs) Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Beta-blockers Market Size (US$ Million) YoY Growth (2015-2026) Figure 14. Global Dilated Cardiomyopathy Therapeutic Market Size Share by Application in 2020 & 2026 Figure 15. Hospitals Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Academic Institutions Market Size (US$ Million) YoY Growth (2015-2026) Figure 17. Dilated Cardiomyopathy Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Top 5 and Top 10 Players Dilated Cardiomyopathy Therapeutic Market Share in 2019 Figure 19. United States Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Canada Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Germany Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. France Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. U.K. Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Italy Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Russia Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Nordic Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Rest of Europe Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. China Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Japan Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. South Korea Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. India Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Australia Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Rest of Asia-Pacific Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Mexico Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Brazil Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Rest of Latin America Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Turkey Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Saudi Arabia Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. UAE Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Rest of Middle East & Africa Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Bottom-up and Top-down Approaches for This Report Figure 43. Data Triangulation

Array BioPharma, Inc. AstraZeneca plc. Celladon Corporation GlaxoSmithKline plc Janssen Pharmaceuticals, Inc. (J&J) Merck & Co., Inc. Novartis International AG Pfizer, Inc. Sanofi S.A. Teva Pharmaceutical Industries Ltd. Vericel Corporation